Oncology Seattle Office $3.375 Billion Exit CPRIT Advisory & Corporate Boards CSAB Members? Uniformed Services University 2014 Top- quartile Ranked San Diego Office New York Office Substantial Exit History $1 Billion Genentech Collaboration Diversity Tachi Yamada, M.D. Pfizer Ventures Operating Partners? Bruce L.A. Carter, Ph.D. Alexandria Venture Investments Top-tier Investors Reviewed > 4,000 Opportunities Apogen Biotechnologies Gates Foundation Steve Gillis, Ph.D. AI & Machine Learning Weill Cornell Medicine 1.02 DPI Scientists & Technology Developers MD Anderson Cancer Center Turn- Key Facilities Divestitures 150+ Years’ Experience 2.85 DVPI Magnolia Neurosciences Entrepreneurs Capital- efficiency Case Western Reserve Exceptional Track Record Non- Dilutive Funding Proniras WRF Capital Syndication Partners Academic & Research Institutions Columbia University Dana Farber Cancer $12.3 Million NIDA Grant Eli Lilly Petra Pharma Singapore Office Jan Lundberg, Ph.D. Gene Yeo, Ph.D. Targeted Therapeutic (Asset) Financing Abbvie Strategic Partnerships Neuroscience & Neurology Leroy Hood, M.D., Ph.D. WuXi PharmaTech Employees Lydian Neurosciences Harvard Medical School (BARDA) – on updated slide deck Sundar Kodiyalam Rodeo Therapeutics Temasek Lodo Therapeutics Penn State University of Minnesota Corporate Spinouts The Rockefeller University UT Southwestern Medical Center Scientific Expertise 58.43% IRR ARCH Venture Partners Oncology Seattle Office $3.375 Billion Exit CPRIT Advisory & Corporate Boards CSAB Members? Uniformed Services University 2014 Top- quartile Ranked San Diego Office New York Office Substantial Exit History $1 Billion Genentech Collaboration Diversity Tachi Yamada, M.D. Pfizer Ventures Operating Partners? Bruce L.A. Carter, Ph.D. Alexandria Venture Investments Top-tier Investors Reviewed > 4,000 Opportunities Apogen Biotechnologies Gates Foundation Steve Gillis, Ph.D. AI & Machine Learning Weill Cornell Medicine 1.02 DPI Scientists & Technology Developers MD Anderson Cancer Center Turn- Key Facilities Divestitures 150+ Years’ Experience 2.85 DVPI Magnolia Neurosciences Entrepreneurs Capital- efficiency Case Western Reserve Exceptional Track Record Non- Dilutive Funding Proniras WRF Capital Syndication Partners Academic & Research Institutions Columbia University Dana Farber Cancer $12.3 Million NIDA Grant Eli Lilly Petra Pharma Singapore Office Jan Lundberg, Ph.D. Gene Yeo, Ph.D. Targeted Therapeutic (Asset) Financing Abbvie Strategic Partnerships Neuroscience & Neurology Leroy Hood, M.D., Ph.D. WuXi PharmaTech Employees Lydian Neurosciences Harvard Medical School (BARDA) – on updated slide deck Sundar Kodiyalam Rodeo Therapeutics Temasek Lodo Therapeutics Penn State University of Minnesota Corporate Spinouts The Rockefeller University UT Southwestern Medical Center Scientific Expertise 58.43% IRR ARCH Venture Partners
(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
I-Oncology
O-Seattle Office
G-$3.375 Billion Exit
N-CPRIT
I-Advisory & Corporate Boards
B-CSAB Members?
G-Uniformed Services University
O-2014 Top-quartile Ranked
B-San Diego Office
G-New York Office
I-Substantial Exit History
O-$1 Billion Genentech Collaboration
N-Diversity
O-Tachi Yamada, M.D.
I-Pfizer Ventures
I-Operating Partners?
N-Bruce L.A. Carter, Ph.D.
B-Alexandria Venture Investments
B-Top-tier Investors
B-Reviewed > 4,000 Opportunities
G-Apogen Biotechnologies
B-Gates Foundation
G-Steve Gillis, Ph.D.
G-AI & Machine Learning
B-Weill Cornell Medicine
O-1.02 DPI
N-Scientists & Technology Developers
I-MD Anderson Cancer Center
G-Turn-Key Facilities
O-Divestitures
B-150+ Years’ Experience
B-2.85 DVPI
I-Magnolia Neurosciences
I-Entrepreneurs
B-Capital-efficiency
I-Case Western Reserve
I-Exceptional Track Record
O-Non-Dilutive Funding
B-Proniras
N-WRF Capital
N-Syndication Partners
B-Academic & Research Institutions
O-Columbia University
I-Dana Farber Cancer
O-$12.3 Million NIDA Grant
G-Eli Lilly
N-Petra Pharma
N-Singapore Office
G-Jan Lundberg, Ph.D.
I-Gene Yeo, Ph.D.
O-Targeted Therapeutic (Asset) Financing
I-Abbvie
G-Strategic Partnerships
N-Neuroscience & Neurology
O-Leroy Hood, M.D., Ph.D.
G-WuXi PharmaTech
I-Employees
N-Lydian Neurosciences
N-Harvard Medical School
B-(BARDA) – on updated slide deck
B-Sundar Kodiyalam
O-Rodeo Therapeutics
O-Temasek
I-Lodo Therapeutics
N-Penn State
B-University of Minnesota
G-Corporate Spinouts
N-The Rockefeller University
G-UT Southwestern Medical Center
N-Scientific Expertise
G-58.43% IRR
O-ARCH Venture Partners